Lane, Adam

Hydroxyurea for children with sickle cell anemia in Sub-Saharan Africa

Tshilolo, L., Tomlinson, G., Williams, T. N., Santos, B., Olupot-Olupot, P., Lane, A., Aygun, B., Stuber, S. E., Latham, T. S., McGann, P. T., et al. (2019) · New England Journal of Medicine

Hemoglobinopathies and Related DisordersBlood groups and transfusion

Cited by 376

Hydroxyurea dose escalation for sickle cell anemia in Sub-Saharan Africa

John, C. C., Opoka, R. O., Latham, T. S., Hume, H. A., Nabaggala, C., Kasirye, P., Ndugwa, C. M., Lane, A., & Ware, R. E. (2020) · New England Journal of Medicine

Hemoglobinopathies and Related DisordersMalaria Research and Control

Cited by 153

Cardiomyopathy With Restrictive Physiology in Sickle Cell Disease

Niss, O., Quinn, C. T., Lane, A., Daily, J., Khoury, P. R., Bakeer, N., Kimball, T. R., Towbin, J. A., Malik, P., & Taylor, M. D. (2016) · JACC: Cardiovascular Imaging

Hemoglobinopathies and Related DisordersCardiovascular Function and Risk Factors

Cited by 142

Robust clinical and laboratory response to hydroxyurea using pharmacokinetically guided dosing for young children with sickle cell anemia

McGann, P. T., Niss, O., Dong, M., Marahatta, A., Howard, T. A., Mizuno, T., Lane, A., Kalfa, T. A., Malik, P., Quinn, C. T., et al. (2019) · American Journal of Hematology

Hemoglobinopathies and Related DisordersPharmaceutical studies and practices

Cited by 105